ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine

Bruna Pellini; Nadja Pejovic; Wenjia Feng; Noah Earland; Peter K. Harris; Abul Usmani; Jeffrey J. Szymanski; Faridi Qaium; Jacqueline Mudd; Marvin Petty; Yuqiu Jiang; Ashla Singh; Christopher A. Maher; Lauren E. Henke; Haeseong Park; Matthew A. Ciorba; Hyun Kim; Matthew G. Mutch; Katrina S. Pedersen; Benjamin R. Tan; William G. Hawkins; Ryan C. Fields; Aadel A. Chaudhuri

Journal ArticleOPEN ACCESS

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine

Pellini B
Pejovic N
Feng W
et al.

JCO Precision Oncology (2021) (5) 378-388

DOI: 10.1200/po.20.00276

N/ACitations

48Readers

Abstract

PURPOSEWe hypothesized that circulating tumor DNA (ctDNA) molecular residual disease (MRD) analysis without prior mutational knowledge could be performed after neoadjuvant chemotherapy to assess ol...

Cite

CITATION STYLE

APA

Pellini, B., Pejovic, N., Feng, W., Earland, N., Harris, P. K., Usmani, A., … Chaudhuri, A. A. (2021). ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine. JCO Precision Oncology, (5), 378–388. https://doi.org/10.1200/po.20.00276

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine

Abstract

Cite

Register to see more suggestions